US FDA Approved Type 2 Diabetes Treatment Of Eli Lilly
On Friday, 13th May 2022, the Food & Drug Administration (FDA) of the United States said, it has approved the injected drug tirzepatide developed by Eli Lilly, which is having the brand name ‘Mounjaro’ for the purpose of helping them to improve the blood sugar control in the adults along with the type 2 diabetes. […]
Continue Reading